A Chinese medicine composition for lifting blood stasis, removing turbidity and its preparation method and application

Through the traditional Chinese medicine composition that lifts and removes blood stasis and changes turbidity, using the effects of medicinal materials such as raw astragalus, the problem of poor effect in the treatment of ejection fraction-retaining heart failure is solved, and the left heart of HFpEF mice has been significantly improved. Diastolic function and quality of life.

CN116549583BActive Publication Date: 2024-11-05THE FIRST AFFILIATED HOSPITAL OF HENAN UNIV OF TCM
View PDF 3 Cites 0 Cited by

Patent Information

Application Number
CN202310555277.X
Authority / Receiving Office
CN · China
Patent Type
Patents(China)
Current Assignee / Owner
Filing Date
2023-05-16
Publication Date
2024-11-05
Estimated Expiration
2043-05-16

AI Technical Summary

Technical Problem

Existing drugs for treating ejection fraction-reducing heart failure are not effective when used for ejection fraction-retaining heart failure (HFpEF) and cannot effectively improve the patient's symptoms and quality of life.

Method used

Provide a traditional Chinese medicine composition for raising and removing stasis and eliminating turbidity, including raw Astragalus, Codonopsis pilosula, Vinegar and Curcuma zedoaria, Red Peony, Cinnamon twig, Salvia, Trichosanthes kirilowii, Pinellia tranquil trunk, Pinellia trunk, Pinellia trunk, Crabenzia, Craben Harmony licorice can improve left heart dilation by invigorating qi and raising depression, promoting blood circulation and unblocking meridians, resolving phlegm and relieving depression, improve left heart diastolic function and blood pressure, and improve exercise endurance.

Benefits of technology

Significantly improving left heart diastolic function, weight, blood pressure and exercise endurance in HFpEF mice, providing a drug that can effectively treat ejection fraction-retaining heart failure.

✦ Generated by Eureka AI based on patent content.

Smart Images

  • Figure CN116549583B_ABST
    Figure CN116549583B_ABST
Patent Text Reader

Abstract

The present invention belongs to the technical field of heart failure drugs, and particularly relates to a Chinese medicine composition for lifting the sunken qi, removing blood stasis and clearing turbidity, and a preparation method and application thereof. The Chinese medicine composition comprises raw astragalus, codonopsis, vinegared curcuma, red peony root, cinnamon twig, allium macrostemon, trichosanthes root, qing pinellia, scutellaria baicalensis, bupleurum, cimicifuga heracleifolia, rhizoma anemarrhenae and roasted liquorice. The Chinese medicine composition has the effects of lifting the sunken qi, removing blood stasis and clearing turbidity, can invigorate qi, lift the sunken qi, activate blood circulation and dredge collaterals, and can also resolve phlegm and relieve depression, so that the atmosphere is filled, the sunken qi is lifted, the chest yang is expanded, the qi and blood are unblocked, the symptoms and the root cause are treated at the same time, and the left ventricular diastolic function, body weight, blood pressure and exercise endurance can be significantly improved. Therefore, the Chinese medicine composition can be used to prepare a drug for treating heart failure with preserved ejection fraction.
Need to check novelty before this filing date? Find Prior Art

Description

Technical Field

[0001] The invention belongs to the technical field of heart failure drugs, and particularly relates to a traditional Chinese medicine composition for lifting blood stasis, removing blood stasis and clearing turbidity, and a preparation method and application thereof. Background Art

[0002] Heart failure with preserved ejection fraction (HFpEF) is a heart failure characterized by left ventricular diastolic dysfunction. There is no disease name for HFpEF in traditional Chinese medicine. Based on its clinical manifestations such as chest tightness, shortness of breath, wheezing, and even angina attacks, it is classified as a disease of palpitations, cough, asthma, edema, etc. Modern medicine believes that HFpEF is a disease of multiple organ dysfunction, involving the comprehensive loss of heart, lung, liver, kidney, skeletal muscle, blood vessels and peripheral reserve function. This is similar to the view of traditional Chinese medicine that HFpEF is mainly caused by the heart, the underlying deficiency is heart, spleen and kidney deficiency, and the superficial excess is mainly phlegm and blood stasis, and it is also related to the liver and lungs.

[0003] Because HFpEF is accompanied by multiple comorbidities and has complex physiological and pathological mechanisms, therapeutic drugs that can improve heart failure with reduced ejection fraction (HFrEF) do not always achieve ideal results when used in HFpEF. It is still necessary to develop drugs that can improve multiple symptoms of HFpEF in order to improve patient symptoms and enhance their survival rate and quality of life. Summary of the invention

[0004] In view of the above technical problems, the present invention provides a Chinese medicine composition for lifting qi, removing blood stasis and removing turbidity, and its preparation method and application. The Chinese medicine composition can replenish qi, lift qi, activate blood circulation and dredge collaterals, and can also resolve phlegm and relieve depression, so that qi can be filled, qi can be lifted, chest yang can be expanded, qi and blood can be unblocked, and the symptoms and root causes can be treated at the same time, and the left ventricular diastolic function, weight, blood pressure and exercise endurance can be improved.

[0005] In order to achieve the above-mentioned object of the invention, the embodiment of the present invention adopts the following technical solution:

[0006] On the one hand, the present invention provides a traditional Chinese medicine composition for lifting sinking, removing blood stasis and clearing turbidity, wherein the raw materials, in proportion by mass fraction, include 24-36 parts of raw astragalus, 16-24 parts of codonopsis pilosula, 12-18 parts of vinegar-curcuma, 12-18 parts of red peony root, 7.2-10.8 parts of cinnamon twig, 16-24 parts of allium macrostemon, 16-24 parts of trichosanthes, 12-18 parts of pinellia tuber, 12-18 parts of scutellaria baicalensis, 4.8-7.2 parts of bupleurum, 4.8-7.2 parts of cimicifuga heracleifolia, 8-12 parts of anemarrhena asphodeloides and 9.6-14.4 parts of roasted liquorice.

[0007] The theory of Zongqi plays an irreplaceable guiding role in the diagnosis and treatment of heart diseases. It was first seen in Huangdi Neijing. Neijing Lingshu Xieke said that "Zongqi accumulates in the chest, comes out of the throat, penetrates the heart veins, and breathes". It is a subtle substance that promotes and maintains heart activity. Zongqi disorder directly affects the function of the heart and lungs. Zongqi "helps the heart to circulate blood", promotes blood circulation, and regulates heart rate and rhythm. When Zongqi is sufficient, the heart qi is abundant, the qi and blood are unobstructed, the spirit is full, and the body is healthy. When Zongqi is insufficient and cannot help the heart to circulate blood, the qi and blood are unbalanced, and a series of heart diseases are formed. Zhang Xichun, a doctor in the late Qing Dynasty, followed the purpose of Huangdi Neijing and proposed the theory of "the sinking of the atmosphere". The atmosphere is Zongqi, the master of life. The atmosphere resides in the chest, breathes, penetrates the heart veins, and is the outline of all qi and blood. Therefore, damage to the atmosphere is an important cause of heart failure. Overwork, long-term illness, misdiagnosis, exogenous factors and other factors can damage the atmosphere in the chest, resulting in "the external air of breathing is not connected with the internal air", that is, the atmosphere sinks, cannot maintain its position (upper Jiao) and sinks to the middle and lower Jiao. Qi is the leader of blood, and blood flows when qi moves. When the atmosphere sinks, it is unable to stop the blood, and the circulation is blocked, resulting in blood stasis. In addition, with the improvement of people's living standards, the faster pace of work and life, overnutrition and irregular diet, the spleen and stomach are damaged, resulting in spleen deficiency, water and moisture cannot be transformed, and phlegm and turbidity are generated internally. Therefore, the present invention proposes for the first time that the sinking of the atmosphere, blood stasis and phlegm turbidity blocking the collaterals are the main pathogenesis of heart failure with preserved ejection fraction. On this basis, the present invention takes ascending the sinking, removing blood stasis and removing turbidity as the main treatment principle for heart failure with preserved ejection fraction, and based on clinical medication experience, provides the above-mentioned traditional Chinese medicine composition for ascending the sinking, removing blood stasis and removing turbidity.

[0008] Raw Astragalus is slightly warm in nature, sweet in taste, and enters the spleen and lung meridians. It has the effects of strengthening the spleen and replenishing the middle, raising yang and lifting the sunken, strengthening the body's defense system, promoting diuresis and reducing swelling, and expelling toxins and promoting tissue regeneration.

[0009] Codonopsis pilosula is mild in nature, sweet in taste, and enters the lung and spleen meridians. It has the effects of tonifying the middle and replenishing qi, strengthening the spleen and lungs, and promoting the production of body fluids and nourishing blood.

[0010] Vinegar Curcuma is warm in nature, bitter and pungent in taste, and enters the liver and spleen meridians. It has the effects of dispelling wind and cold, unblocking meridians, promoting qi and removing blood, and eliminating accumulation and relieving pain.

[0011] Red peony root is slightly cold in nature, bitter in taste, and enters the liver meridian. It has the effects of clearing liver fire, cooling blood, activating blood circulation, dispersing blood stasis and relieving pain.

[0012] Cinnamon twig is warm in nature, pungent and sweet in taste, and enters the heart and lung meridians. It has the effects of sweating and relieving muscles, dispelling cold and relieving pain, warming and unblocking meridians, and promoting yang and transforming qi.

[0013] Xiebai is warm in nature, pungent and bitter in taste, and enters the heart, lung, stomach, and large intestine meridians. It has the effects of regulating qi, relaxing the middle, promoting yang and dispersing nodules, and promoting qi and removing stagnation.

[0014] Trichosanthes root is cold in nature and sweet in taste. It enters the lung, stomach and large intestine meridians and has the effects of clearing the lungs and moistening dryness, clearing away heat and removing phlegm, promoting qi and relieving chest tightness, reducing swelling and dispersing stagnation, and moistening the intestines and relieving constipation.

[0015] Qing Banxia is warm in nature, pungent in taste, and enters the spleen, stomach, and lung meridians. It has the effects of drying dampness and resolving phlegm, relieving adverse effects and stopping vomiting, and softening and dispersing lumps.

[0016] The seeds of the herb are cold in nature, bitter and pungent in taste, and enter the lung and bladder meridians. They have the effects of purging the lungs and lowering qi, removing phlegm and relieving asthma, promoting diuresis and reducing swelling, and purging heat and expelling pathogens.

[0017] Bupleurum root is slightly cold in nature, bitter in taste, and enters the liver and gallbladder meridians. It has the effects of reconciling the exterior and interior, dispersing heat, relieving liver depression, and raising yang and lifting sunken organs.

[0018] Cimicifuga heracleifolia is slightly cold in nature, pungent and sweet in taste, and enters the lung, spleen, large intestine, and stomach meridians. It has the effects of relieving rashes, clearing away heat and detoxifying, and raising yang and lifting sunken qi.

[0019] Anemarrhena, cold in nature, bitter and sweet in taste, enters the lung, stomach and kidney meridians, has the effects of clearing away heat and purging fire, nourishing yin and moistening dryness;

[0020] Roasted licorice root is mild in nature, sweet in taste, and enters the heart, spleen, lung, and stomach meridians. It has the effects of tonifying the spleen and stomach, nourishing yin and blood, invigorating qi and promoting yang, and restoring the pulse and calming palpitations.

[0021] The Chinese medicine composition provided by the present invention uses Astragalus as the main ingredient, which is good at both replenishing Qi and raising Qi, and raising the sunken Qi.

[0022] The minister uses Codonopsis pilosula to nourish the spleen and benefit the source of acquired qi and blood production; Curcuma zedoaria and red peony root are used to dissipate blood stasis and dredge the meridians; Cinnamon twig, Trichosanthes, Allium macrostemon, Pinellia ternata and Lemongrass are used to invigorate yang and disperse nodules, dispel phlegm and turbidity, and purge the lungs and relieve asthma;

[0023] With Bupleurum and Cimicifuga, it can both lift the sunken and relieve depression, and the cool nature of Anemarrhena can control the warm nature of Astragalus.

[0024] Roasted licorice can replenish qi and strengthen the spleen, and can also harmonize various medicines.

[0025] The combination of these medicines can not only replenish Qi and lift sunken Qi, activate blood circulation and dredge meridians, but also resolve phlegm and relieve depression, so that the great energy can be replenished, sunken Qi can be lifted, the chest yang can be expanded, Qi and blood can flow smoothly, treating both the symptoms and the root cause.

[0026] Experimental results show that the Chinese medicine composition provided by the present invention can significantly improve the left ventricular diastolic function, body weight, blood pressure and exercise tolerance of HFpEF mice.

[0027] Preferably, the raw materials of the traditional Chinese medicine composition include 27-33 parts of raw astragalus, 18-22 parts of codonopsis pilosula, 13.5-16.5 parts of vinegared zedoaria, 13.5-16.5 parts of red peony root, 8.1-9.9 parts of cinnamon twig, 18-22 parts of allium macrostemon, 18-22 parts of trichosanthes, 13.5-16.5 parts of pinellia, 13.5-16.5 parts of leonuri, 5.4-6.6 parts of bupleurum, 5.4-6.6 parts of cimicifuga, 9-11 parts of anemarrhena and 10.8-13.2 parts of roasted liquorice.

[0028] Preferably, the raw materials of the traditional Chinese medicine composition include 30 parts of raw astragalus, 20 parts of codonopsis pilosula, 15 parts of vinegared curcuma, 15 parts of red peony root, 9 parts of cinnamon twig, 20 parts of allium macrostemon, 20 parts of trichosanthes, 15 parts of pinellia, 15 parts of leonuri, 6 parts of bupleurum, 6 parts of cimicifuga, 10 parts of anemarrhena and 12 parts of roasted liquorice.

[0029] In a second aspect, the present invention also provides a method for preparing the above-mentioned Chinese medicine composition, comprising: extracting the raw material with water. The obtained extract can be directly concentrated and dried before use, or the extract or the dried product can be prepared into a commonly used clinical preparation together with an excipient before use.

[0030] Preferably, the mass of the water is 6 to 10 times the mass of the raw material.

[0031] Preferably, the extraction method is decoction extraction, the extraction is performed 2 to 3 times, each extraction time can be selected to be 40 to 80 minutes, preferably 2 extractions, each time for 1 hour.

[0032] In a fifth aspect, an embodiment of the present invention further provides the use of the above-mentioned Chinese medicine composition or the Chinese medicine composition prepared by the above-mentioned preparation method in the preparation of a drug for treating heart failure with preserved ejection fraction.

[0033] Preferably, the drug is an oral preparation.

[0034] After the Chinese medicine composition provided by the present invention is made into an oral preparation, it can be administered orally to play the role of treating heart failure with preserved ejection fraction.

[0035] Preferably, the medicament further comprises an excipient.

[0036] The obtained Chinese medicine extract is extracted and then prepared with excipients into a conventional oral preparation to obtain the product.

[0037] Preferably, the drug is a drug for treating heart failure with preserved ejection fraction accompanied by hyperlipidemia. BRIEF DESCRIPTION OF THE DRAWINGS

[0038] Figure 1 is the ejection fraction (EF) of the three groups of mice in Example 12;

[0039] Figure 2 is the blood flow velocity ratio (E / A) during early ventricular diastole and late ventricular diastole of the three groups of mice in Example 12;

[0040] Figure 3 is the maximum rate of decrease of left ventricular pressure during isovolumetric relaxation of the three groups of mice in Example 12 (dp / dt max);

[0041] Figure 4 is the minimum rate of decrease of left ventricular pressure during isovolumetric relaxation of the three groups of mice in Example 12 (dp / dt min);

[0042] Figure 5 is the ratio of heart weight to tibia length (HW / TL) of the three groups of mice in Example 12;

[0043] Figure 6 is the body weight of the three groups of mice in Example 12;

[0044] Figure 7 is the systolic blood pressure of the three groups of mice in Example 12;

[0045] Figure 8 is the diastolic blood pressure of the three groups of mice in Example 12;

[0046] Fig. 9 is the exhaustion displacement of the three groups of mice in Example 12;

[0047] Fig.10 is the exhaustion time of the three groups of mice in Example 12;

[0048] above Figures 1 to 10 Middle: ** indicates comparison with control, p<0.01; ## indicates comparison with Model, p<0.01; # indicates comparison with Model, p<0.05. DETAILED DESCRIPTION

[0049] In order to make the purpose, technical solution and advantages of the present invention more clearly understood, the present invention is further illustrated in conjunction with specific embodiments below. It should be understood that the specific embodiments described herein are only used to explain the present invention and are not used to limit the present invention.

[0050] The raw astragalus, codonopsis, vinegar curcuma, red peony root, cinnamon twig, allium macrostemon, trichosanthes, pinellia tuber, scutellaria baicalensis, bupleurum, cimicifuga, anemarrhena and roasted licorice used in the following examples all comply with the relevant provisions under each medicinal material item in the main text of the Chinese Pharmacopoeia (2020 edition).

[0051] Unless otherwise specified, the raw materials, reagents, etc. used in the following examples were obtained from commercial sources.

[0052] Example 1

[0053] The embodiment of the present invention provides a traditional Chinese medicine composition for lifting, removing blood stasis and clearing turbidity, wherein the raw materials include 30 parts of raw astragalus, 20 parts of codonopsis, 15 parts of vinegar-curcuma, 15 parts of red peony root, 9 parts of cinnamon twig, 20 parts of allium macrostemon, 20 parts of trichosanthes, 15 parts of qingbanxia, ​​15 parts of scutellaria, 6 parts of bupleurum, 6 parts of cimicifuga, 10 parts of anemarrhena and 12 parts of roasted liquorice.

[0054] The preparation method is as follows: take the above-mentioned Chinese herbal medicine slices, first decoct and extract with 8 times the amount of water for 1 hour, filter the extract, then decoct the residue with 7 times the amount of water for 1 hour, filter the extract, combine the filtrate, and concentrate under reduced pressure at 50°C to a clear paste with a relative density of 1.10-1.20 (70°C).

[0055] Example 2

[0056] The embodiment of the present invention provides a traditional Chinese medicine composition for lifting, removing blood stasis and clearing turbidity, wherein the raw materials include 27 parts of raw astragalus, 22 parts of codonopsis, 13.5 parts of vinegar-curcuma, 16.5 parts of red peony root, 8.1 parts of cinnamon twig, 22 parts of allium macrostemon, 22 parts of trichosanthes, 13.5 parts of quercetin, 13.5 parts of scutellaria, 5.4 parts of bupleurum, 6.6 parts of cimicifuga, 9 parts of anemarrhena and 10.8 parts of roasted liquorice.

[0057] The preparation method is as follows: take the above-mentioned Chinese herbal medicine slices, first decoct and extract with 8 times the amount of water for 1 hour, filter the extract, then decoct the residue with 7 times the amount of water for 1 hour, filter the extract, combine the filtrate, and concentrate under reduced pressure at 50°C to a clear paste with a relative density of 1.10-1.20 (70°C).

[0058] Example 3

[0059] The embodiment of the present invention provides a traditional Chinese medicine composition for lifting, removing blood stasis and clearing turbidity, wherein the raw materials include 33 parts of raw astragalus, 18 parts of codonopsis, 16.5 parts of vinegar-curcuma, 13.5 parts of red peony root, 9.9 parts of cinnamon twig, 18 parts of allium macrostemon, 18 parts of trichosanthes, 16.5 parts of quercetin, 16.5 parts of scutellaria, 6.6 parts of bupleurum, 5.4 parts of cimicifuga, 11 parts of anemarrhena and 13.2 parts of roasted liquorice.

[0060] The preparation method is as follows: take the above-mentioned Chinese herbal medicine slices, first decoct and extract with 8 times the amount of water for 1 hour, filter the extract, then decoct the residue with 7 times the amount of water for 1 hour, filter the extract, combine the filtrate, and concentrate under reduced pressure at 50°C to a clear paste with a relative density of 1.10-1.20 (70°C).

[0061] Example 4

[0062] The embodiment of the present invention provides a traditional Chinese medicine composition for lifting, removing blood stasis and clearing turbidity, wherein the raw materials include 24 parts of raw astragalus, 24 parts of codonopsis, 12 parts of vinegar-curcuma, 18 parts of red peony root, 7.2 parts of cinnamon twig, 24 parts of allium macrostemon, 24 parts of trichosanthes, 12 parts of qingbanxia, ​​12 parts of scutellaria, 4.8 parts of bupleurum, 7.2 parts of cimicifuga, 8 parts of anemarrhena and 9.6 parts of roasted liquorice.

[0063] The preparation method is as follows: take the above-mentioned Chinese herbal medicine slices, first decoct and extract with 10 times the amount of water for 80 minutes, filter the extract, then decoct the residue with 6 times the amount of water for 40 minutes, filter the extract, combine the filtrate, and concentrate under reduced pressure at 50°C to a clear paste with a relative density of 1.10-1.20 (70°C).

[0064] Example 5

[0065] The embodiment of the present invention provides a traditional Chinese medicine composition for lifting, removing blood stasis and clearing turbidity, wherein the raw materials include 36 parts of raw astragalus, 16 parts of codonopsis, 18 parts of vinegar-curcuma, 12 parts of red peony root, 10.8 parts of cinnamon twig, 16 parts of allium macrostemon, 16 parts of trichosanthes, 18 parts of quercetin, 18 parts of scutellaria, 7.2 parts of bupleurum, 4.8 parts of cimicifuga, 12 parts of anemarrhena and 14.4 parts of roasted liquorice.

[0066] The preparation method is as follows: take the above-mentioned Chinese herbal medicine slices, first decoct and extract with 10 times the amount of water for 80 minutes, filter the extract, then decoct the residue with 6 times the amount of water for 40 minutes, filter the extract, combine the filtrate, and concentrate under reduced pressure at 50°C to a clear paste with a relative density of 1.10-1.20 (70°C).

[0067] Example 6

[0068] An embodiment of the present invention provides an application of the Chinese medicine composition obtained in Example 1 in preparing tablets for treating heart failure with preserved ejection fraction. The specific method is: adding pharmaceutically acceptable excipients of the corresponding dosage form to the Chinese medicine composition obtained in Example 1 according to the desired dosage form, and preparing it according to the conventional method of the dosage form.

[0069] This method can also be used for the Chinese medicine compositions obtained in Examples 2 to 5.

[0070] Example 7

[0071] The embodiment of the present invention provides a Chinese medicine granule for lifting depression, removing blood stasis and clearing turbidity, and the preparation method thereof is: mixing the clear paste obtained in any one of embodiments 1 to 5 with dextrin, granulating into 18-20 mesh, drying at 50-60° C., granulating into 20-22 mesh, and packaging to obtain the granule.

[0072] Dextrin can be replaced by other pharmaceutically acceptable granule excipients. Excipients such as flavoring agents can also be added to the granules according to clinical needs.

[0073] Example 8

[0074] The embodiment of the present invention provides a Chinese medicine tablet for lifting depression, removing blood stasis and clearing turbidity, and the preparation method thereof is as follows: the clear paste obtained in any one of embodiments 1 to 5 is mixed with starch and dextrin, granulated into 22 to 24 meshes, dried at 50 to 60° C. and granulated into 24 to 26 meshes, 2% cross-linked polyvinylpyrrolidone, 1% magnesium stearate and 1% talc are added, and tabletted to obtain the tablet.

[0075] Starch and dextrin can be replaced by other pharmaceutically acceptable fillers, cross-linked polyvinylpyrrolidone can be replaced by other pharmaceutically acceptable disintegrants, and magnesium stearate and talc can be replaced by other pharmaceutically acceptable lubricants. The tablet can also be film-coated according to clinical needs.

[0076] Example 9

[0077] The embodiment of the present invention provides a Chinese medicine hard capsule for lifting depression, removing blood stasis and clearing turbidity. The preparation method of the hard capsule is as follows: the clear paste obtained in any one of embodiments 1 to 5 is mixed with dextrin, granulated into 18-20 mesh, dried at 50-60° C. and granulated into 20-22 mesh, 1% magnesium stearate is added, and the hard capsule shell is filled to obtain the hard capsule.

[0078] Dextrin may be replaced by other pharmaceutically acceptable fillers, and magnesium stearate may be replaced by other pharmaceutically acceptable lubricants.

[0079] Example 10

[0080] The embodiment of the present invention provides a Chinese medicine powder for lifting depression, removing blood stasis and clearing turbidity. The preparation method of the Chinese medicine powder is as follows: the clear paste obtained in any one of embodiments 1 to 5 is dried at 50 to 60° C., crushed, and packaged to obtain the powder.

[0081] The powder can be added with pharmaceutically acceptable powder excipients according to clinical needs.

[0082] Embodiment 11

[0083] The embodiment of the present invention provides a Chinese medicine soft capsule for lifting depression, removing blood stasis and clearing turbidity. The preparation method of the soft capsule is as follows: the clear paste obtained in any one of embodiments 1 to 5 is mixed with soybean oil, and the soft capsule is pressed into a soft capsule using a capsule skin in a soft capsule pressing machine.

[0084] Soybean oil can be replaced by other pharmaceutically acceptable soft capsule content fillers.

[0085] Example 12

[0086] The examples of the present invention provide the effects of the Chinese medicine composition obtained in Example 1 on left ventricular diastolic function, body weight, blood pressure and exercise tolerance in mice with heart failure with preserved ejection fraction.

[0087] 1. Modeling and drug intervention

[0088] 8-week-old male C57BL / 6 mice were divided into 3 groups, including a blank group (Control), a model group (Model) and a drug-treated group (SXQYHZ), with 8 mice in each group. The standard feeding method for mice was adopted, and the light and dark environment was alternated every 12h. The experiment was started after one week of adaptive feeding. Among them, the blank group was given a control feed (D12450B adjustment type, Beijing Xiaoshu Youtai Biotechnology Co., Ltd.) and normal water; the model group and the drug-treated group were given a high-fat feed (D12492, Beijing Xiaoshu Youtai Biotechnology Co., Ltd.) combined with 0.5g / L Nω-nitro-I-arginine methyl ester drinking water for 16 weeks to induce a heart failure with preserved ejection fraction (HFpEF) model. After 16 weeks, the drug-treated group was given the Chinese medicine composition obtained in Example 1, and 0.1mL volume was given per 10g and gavaged once a day, and the dosage was 5.2g / kg / d (in terms of crude drug), and the drug was administered for 6 weeks. Both the normal group and the model group were given an equal volume of ultrapure water by gavage.

[0089] 2. Results

[0090] 2.1 Left ventricular diastolic function

[0091] The results are as follows Figure 1 As shown, there was no significant change in ejection fraction among the three groups of mice; Figure 2 to Figure 5 As shown in the figure, compared with the Control group, the E / A and dp / dt max of the Model group were significantly decreased, and dp / dt min and HW / TL were significantly increased; after treatment with the Chinese medicine composition obtained in Example 1, the E / A and dp / dt max of the SXQYHZ group were significantly increased, and dp / dt min and HW / TL were significantly decreased compared with the Model group. It can be seen that the Chinese medicine composition obtained in Example 1 can improve the left ventricular diastolic function of HFpEF mice.

[0092] 2.2 Weight, blood pressure and exercise tolerance

[0093] The results are as follows Figure 6 to Figure 10 As shown, compared with the Control group, the body weight, systolic blood pressure, and diastolic blood pressure of the mice in the Model group were significantly increased, and the exhaustion displacement and exhaustion time were significantly decreased; after treatment with the Chinese medicine composition obtained in Example 1, the body weight, systolic blood pressure, and diastolic blood pressure of the mice in the SXQYHZ group were significantly reduced compared with the Model group, and the exhaustion displacement and exhaustion time were significantly improved. It can be seen that the Chinese medicine composition obtained in Example 1 can improve the body weight, blood pressure, and exercise endurance of HFpEF mice.

[0094] The above description is only a preferred embodiment of the present invention and is not intended to limit the present invention. Any modification, equivalent substitution or improvement made within the spirit and principle of the present invention should be included in the protection scope of the present invention.

Claims

1. A Chinese medicine composition for lifting qi, removing blood stasis and clearing turbidity, It is characterized in that The mass ratio of the raw materials is: 24~36 parts of raw astragalus, 16~24 parts of Codonopsis pilosula, 12~18 parts of vinegar-soaked Curcuma, 12~18 parts of red peony root, 7.2~10.8 parts of cinnamon twig, 16~24 parts of Allium macrostemon, 16~24 parts of Trichosanthes, 12~18 parts of Pinellia ternata, 12~18 parts of Lemongrass seeds, 4.8~7.2 parts of Bupleurum, 4.8~7.2 parts of Cimicifuga heracleifolia, 8~12 parts of Anemarrhena asphodeloides and 9.6~14.4 parts of roasted Licorice root.

2. The Chinese medicine composition for lifting blood stasis, removing turbidity and removing blood stasis according to claim 1, It is characterized in that The mass ratio of the raw materials is: 27~33 parts of raw astragalus, 18~22 parts of Codonopsis pilosula, 13.5~16.5 parts of vinegar-soaked Curcuma, 13.5~16.5 parts of red peony root, 8.1~9.9 parts of cinnamon twig, 18~22 parts of Allium macrostemon, 18~22 parts of Trichosanthes, 13.5~16.5 parts of Pinellia ternata, 13.5~16.5 parts of Lemongrass seeds, 5.4~6.6 parts of Bupleurum, 5.4~6.6 parts of Cimicifuga heracleifolia, 9~11 parts of Anemarrhena asphodeloides and 10.8~13.2 parts of roasted Licorice root.

3. The Chinese medicine composition for lifting stasis, removing blood stasis and clearing turbidity according to claim 2, It is characterized in that The mass ratio of the raw materials is: 30 parts of raw astragalus, 20 parts of codonopsis, 15 parts of vinegar-soaked curcuma, 15 parts of red peony root, 9 parts of cinnamon twig, 20 parts of allium macrostemon, 20 parts of trichosanthes, 15 parts of pinellia, 15 parts of scutellaria, 6 parts of bupleurum, 6 parts of cimicifuga, 10 parts of anemarrhena and 12 parts of roasted liquorice.

4. A method for preparing the Chinese medicine composition according to any one of claims 1 to 3, It is characterized in that The drug substance is extracted with water.

5. The preparation method according to claim 4, It is characterized in that The mass of the water is 6 to 10 times the mass of the raw material drug.

6. The preparation method according to claim 4, It is characterized in that The extraction method is decoction extraction, which is performed 2 to 3 times, with each extraction time being 40 to 80 minutes.

7. Use of the Chinese medicine composition according to any one of claims 1 to 3 or the Chinese medicine composition prepared by the preparation method according to any one of claims 4 to 6 in the preparation of a medicament for treating heart failure with preserved ejection fraction.

8. The use according to claim 7, It is characterized in that The medicine is an oral preparation.

9. The use according to claim 7, It is characterized in that The medicament further comprises an excipient.

10. The use according to any one of claims 7 to 9, It is characterized in that The medicine is a medicine for treating heart failure with preserved ejection fraction accompanied by hyperlipidemia.

Citation Information

Patent Citations

  • Traditional Chinese medicine decoction for treating sick sinus syndrome

    CN102526452A

  • Traditional Chinese medicine composition for preventing and treating heart failure after myocardial infarction as well as traditional Chinese medicine preparation and application thereof

    CN114796415A

  • Traditional Chinese medicine composition for treating chronic heart failure and application thereof

    CN115969928A